The largest database of trusted experimental protocols

4 protocols using embryomax 0.1 gelatin solution

1

Extracellular Action Potential Recordings of NRVCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
NRVCs were plated on MEA plates (Multichannel Systems, Germany) pre-coated with EmbryoMax® 0.1% Gelatin Solution (Millipore) at a density of 1000 cells/mm2. Each MEA plate contains 60 titanium nitrate (TiN) electrodes with diameter of 30 μM positioned in a rectangular grid. Extracellular action potential was recorded at initial state before any transduction using MEA-1060 system (Multichannel Systems, Germany). Cells were then transduced with either Ad-Tat or Ad-null and extracellular action potential was recorded post transduction. The sampling frequency was set to 2000 kHz and an online built-in bandpass filter was utilized throughout the recording. Data were recorded using the MC_Rack software and further analyzed with MATLAB®.
+ Open protocol
+ Expand
2

Macrophage Differentiation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
RPMI medium, DPBS without Ca2+ and Mg2+, penicillin-streptomycin, Glutamax, microplate BCA protein assay, trypsin-EDTA, and TEAB were from Thermo Scientific, Waltham, MA, USA; trypsin protease-MS grade, sodium dodecyl sulphate, acetonitrile, HPLC-grade ethanol, and water were from Sigma, Dorset, UK; human Fc block and Alexa Fluor® anti-human CD300A Cat# 566342 were from BD Bioscience, Berkshire, UK; PE anti-human CD68 Cat# 130-118-486 was from Miltenyi Biotec, Surrey, UK; PE anti-human CD109 Cat# 323305, APC anti-human LILRB2 Cat# 338707, APC anti-human Siglec-10 Cat# 347606, APC anti-human CD206 Cat# 321109, APC anti-human CD80 Cat# 305219, APC anti-human CD86 Cat# 374208, PE/Cy7 anti-human CD14 Cat# 367112, and recombinant human M-CSF were from Biolegend, San Diego, CA, USA. X-VIVO15 Serum free medium Cat# BE02-060Q was from Lonza, Basel, Switzerland. Recombinant human BMP4 (Cat# 120-05), SCF (Cat# 300-07), VEGF (Cat# 100-20) and IL-3 (Cat# 200-03) were from Peprotech, London, UK. EmbryoMax® 0.1% Gelatin solution was from Millipore, London, UK. Y-27632 (Cat# 1254/10) was from Bio-Techne, Abingdon, UK.
+ Open protocol
+ Expand
3

Feeder-free Maintenance of Undifferentiated ESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Undifferentiated ESCs were maintained feeder free on gelatin (EmbryoMax 0.1% gelatin solution, ES-006-B; Millipore)-coated plates, in knockout DMEM (10829-018; Gibco), 20% knockout serum replacement (KSR, 10828-028; Gibco), 2 mM L-glutamine (25030-024; Gibco), 1x minimal essential medium nonessential amino acids (11140-035; Gibco), 1× penicillin-streptomycin (15140-122; Gibco), 100 μM β-mercaptoethanol (31350; Gibco) and 1,000 U/mL recombinant LIF (ESG1107; Chemicon International).
+ Open protocol
+ Expand
4

Maintenance and Wnt Activation of Mouse ESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
R1 and E14Tg2 mouse ESCs were maintained feeder-free on gelatin- (EmbryoMax 0.1% Gelatin Solution, ES-006-B; Millipore) coated plates in DMEM (41965–039 Gibco), 15% fetal bovine serum (Sigma), 2 mM L-glutamine (25030–024; Gibco), 1X minimal essential medium non-essential amino acids (Gibco), penicillin (100 U/ml) /streptomycin (100U/ml) (15140122; Gibco), 100 μM β-Mercaptoethanol (Gibco) and 1,000 U/ml recombinant mouse leukemia inhibitory factor (ESG1107; ESGRO, Chemicon International). mESCs were treated at indicated concentrations to activate the Wnt pathway: purified Wnt3a (315–20; Peprotech); BIO (361550; Calbiochem); CHIR99021 (361571; Calbiochem). BIO and CHIR99021 were resuspended in DMSO (Sigma) at a stock concentration of 2 mM (BIO) and 6 or 10 mM (CHIR99021), Wnt3a (Peprotech) was resuspended at a stock concentration of 50ng/μL following manufacturer instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!